Gene therapy for haemophilia A using Roctavian and lentivirus vector shows promise in treating the rare, hereditary condition ...

The US FDA has granted clearance to SpliceBio’s IND application to begin the trial of SB-007, designed for Stargardt disease treatment.

This article explores the latest techniques and workflows for purification across biopharmaceuticals including vaccines, ...

Expression Therapeutics, Inc., has presented the results of a Phase 1 clinical trial for its novel lentiviral vector-based gene therapy ? ET3 ? for hemophilia A at the Annual Meeting of the American ...

India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...

For his performance, he’s widely expected to land his first Oscar nomination. For Guadagnino, making “Queer” is especially long in coming. He first read the book – written in the early ‘ ...

New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.

As COVID-19 and flu season ramp up, another virus is making headlines: “Bleeding eyes” virus, also known as the Marburg virus. The U.S. State Department is warning Americans against traveling ...

When his 3-year-old son, Marcel, grows up, the burly French mariner wants to be able to explain what he did to make a dent in the the shipping industry’s huge carbon footprint. The international ...

Respiratory syncytial virus, commonly known as RSV, is a common respiratory infection that affects children and adults. Most children contract RSV before the age of 2. RSV is not usually a serious ...

Viral Vector Development MarketThe Viral Vector Development Market is set for impressive growth, with its valuation expected to rise from USD 730.7 million in 2023 to USD 4.1 billion by 2033, ...